Objectives-Osteocalcin is the major non-coliagenous protein of bone and is regarded as a specific index of bone formation. The aim of this study was to examine the rate of bone formation measured by osteocalcin in 38 patients with ankylosing spondylitis (AS) and its dependence on various parameters of calcium and phosphate metabolism. Methods-Serum osteocalcin, alkaline phosphatase, parathyroid hormone, and 1,25-dihydroxyvitamin D were measured in 38 patients with ankylosing spondylitis and in 52 controls. Results-Mean serum osteocalcin was significantly reduced in patients with AS (men 1*7 (1.1) ng/ml; women 1-2 (1.1) ng/ml) compared with the corresponding control groups (men 3-2 (1.3) ng/ml; women 4-1 (1.7) nglml). Although they have been useful in measuring bone turnover, they also have significant limitations.7 8 y-Carboxyglutamic acid containing protein of bone, the most abundant protein of bone derived from osteoblasts,9 is a specific marker of bone formation. The synthesis of this protein, usually called osteocalcin, is regulated by calciotropic hormones.'01 In particular, 1,25-dihydroxyvitamin D stimulates the production of osteocalcin in osteoblasts.'0 The aim of this study was to examine the rate of bone formation (measured by the amount of osteocalcin) in patients with AS and its dependence on various parameters of calcium phosphate metabolism, especially parathyroid hormone and 1 ,25-dihydroxyvitamin D.
Patients with ankylosing spondylitis (AS) are known to have a certain degree of osteopenia.'`3 Clinically, vertebral osteoporosis is a well recognised radiological feature. Reid et al showed a reduction in mean total body calcium by 5 .30/o in 20 patients with AS. 4 The pathogenesis of this osteopenia already seen in early AS5 is controversial3 5 and few data exist on bone turnover. 6 Alkaline phosphatase, hydroxyproline, and other collagen related substances have been widely used as biochemical markers for bone metabolism.
Although they have been useful in measuring bone turnover, they also have significant limitations.7 8 y-Carboxyglutamic acid containing protein of bone, the most abundant protein of bone derived from osteoblasts,9 is a specific marker of bone formation. The synthesis of this protein, usually called osteocalcin, is regulated by calciotropic hormones.'01 In particular, 1,25-dihydroxyvitamin D stimulates the production of osteocalcin in osteoblasts.'0 The aim of this study was to examine the rate of bone formation (measured by the amount of osteocalcin) in patients with AS and its dependence on various parameters of calcium phosphate metabolism, especially parathyroid hormone and 1 ,25-dihydroxyvitamin D.
Patients and methods
The study group The sensitivity of the assay was 0-2 ng/ml and the concentration could be determined in all patients. In all cases the intraassay variation was less than 8% and the interassay variation was less than 12%. Parathyroid hormone was determined by a commercial radioimmunoassay (Fleurus, Belgium) using chicken antibody raised against human parathyroid hormone (c terminal). showed low osteocalcin levels in patients with hypoparathyroidism. In contrast, levels of parathyroid hormone in our patients were at the upper limit of normal values. Consequently, serum 1,25-dihydroxyvitamin D3, the synthesis of which is stimulated by parathyroid hormone, was slightly but not significantly (p>0 05) increased. Although serum calcium and phosphate levels were in the normal range, it is conceivable that low bone formation leads to a net loss of calcium, being compensated for by a slight increase of parathyroid hormone (as discussed in osteoporosis type II) and 1,25-dihydroxyvitamin D in some patients with AS. Our studies show, however, that these two calciotropic hormones, which have a stimulating influence on osteocalcin synthesis, are not responsible for low levels of osteocalcin as they are in the upper limit of the normal range in patients with AS.
Our results indicate that bone turnover in patients with AS is characterised by low bone formation in the presence of normal levels of calcium regulating hormones. 
